Target intelligence / Profile preview

Commensal intestinal flora modulation

Molecular classification
Other (this refers to a community of organisms and their modulation, not a molecular classification such as receptor, enzyme, etc.)
01

Overview

The term “commensal intestinal flora modulation” refers to any intervention or process that alters the composition, function, or activity of the indigenous microbes inhabiting the intestinal tract. These microbes are primarily bacteria but also include archaea, fungi, and viruses. Modulation of the gut microbiota can impact a broad range of host physiological processes including digestion, immune function, metabolite production, and disease susceptibility. Therapeutic modulation can be approached via probiotics, prebiotics, antibiotics, dietary interventions, and fecal microbiota transplantation. This is not a single molecular target but a collective term for a complex biological ecosystem whose balance and activity are central to health and disease.

Other names
Gut microbiota modulationGut flora modulationIntestinal microbiota modulationCommensal microbiome modulation
02

Mechanism of action

Restoration of healthy microbial balance Suppression of pathogenic species Enhancement of beneficial metabolite production (such as short-chain fatty acids) Modulation of gut barrier integrity Modulation of immune signaling pathways (e.g., via Toll-like receptors and nucleotide-binding oligomerization domain-like receptor pathways)

03

Biological functions

Immune response regulationMetabolic homeostasisNutrient absorptionResistance to infectionMaintenance of intestinal barrier functionModulation of inflammationNeurological signaling via the gut-brain axis
04

Disease associations

InfectionInflammationGastrointestinal disorders (including constipation, IBS, IBD)Metabolic disordersNeuropsychiatric disorders
05

Safety considerations

Unintended dysbiosisInfections (via probiotic organisms or fecal transplant)Altered immune responsesTransmission of antibiotic resistance genes (particularly with FMT)
06

Interacting drugs

Probiotics (e.g., Lactobacillus spp., Bifidobacterium spp.)

4 more in the full profile.

07

Biomarkers

Microbial diversity indices (Shannon index, etc.)Abundance of specific genera/species (e.g., Bacteroides, Firmicutes, Bifidobacterium)Short-chain fatty acid levels (butyrate, propionate, acetate)Fecal calprotectin (for intestinal inflammation)Metagenomic sequencing profiles

Beyond the preview

Go deeper on Commensal intestinal flora modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Commensal intestinal flora modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call